Metabolic Bariatric Surgery Declines as GLP-1 Drug Use Increases

According to a research letter published in JAMA Surgery, the popularity of glucagon-like peptide-1 (GLP-1) medications is increasing. Concurrently with this trend, a decrease in the number of metabolic bariatric surgeries has been observed. This development suggests a connection between the increased use of GLP-1 drugs and a reduced demand for surgical procedures.